| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 33867* | 2014 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 28767* | 2016 |
| Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice … JD Douketis, AC Spyropoulos, FA Spencer, M Mayr, AK Jaffer, ... Chest 141 (2), e326S-e350S, 2012 | 3109* | 2012 |
| 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] DCW Lau, JD Douketis, KM Morrison, IM Hramiak, AM Sharma, E Ur Cmaj 176 (8), S1-S13, 2007 | 1651 | 2007 |
| Systematic overview of warfarin and its drug and food interactions AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ... Archives of internal medicine 165 (10), 1095-1106, 2005 | 1558 | 2005 |
| A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ... New England Journal of Medicine 340 (12), 901-907, 1999 | 1503 | 1999 |
| Perioperative bridging anticoagulation in patients with atrial fibrillation JD Douketis, AC Spyropoulos, S Kaatz, RC Becker, JA Caprini, AS Dunn, ... New England Journal of Medicine 373 (9), 823-833, 2015 | 1328 | 2015 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1247 | 2008 |
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome MA Crowther, JS Ginsberg, J Julian, J Denburg, J Hirsh, J Douketis, ... New England Journal of Medicine 349 (12), 1133-1138, 2003 | 1116 | 2003 |
| Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis LA Linkins, PT Choi, JD Douketis Annals of internal medicine 139 (11), 893-900, 2003 | 1007 | 2003 |
| Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION ... Anesthesiology 120 (3), 564-578, 2014 | 979 | 2014 |
| Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice JD Douketis, C Macie, L Thabane, DF Williamson International journal of obesity 29 (10), 1153-1167, 2005 | 935 | 2005 |
| Risk of fatal pulmonary embolism in patients with treated venous thromboembolism JD Douketis, C Kearon, S Bates, EK Duku, JS Ginsberg Jama 279 (6), 458-462, 1998 | 861 | 1998 |
| Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with … AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ... Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020 | 796* | 2020 |
| Low-molecular-weight heparin in the treatment of patients with venous thromboembolism Columbus Investigators New England Journal of Medicine 337 (10), 657-662, 1997 | 774 | 1997 |
| Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY … JS Healey, J Eikelboom, J Douketis, L Wallentin, J Oldgren, S Yang, ... Circulation 126 (3), 343-348, 2012 | 723 | 2012 |
| A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding … LR Dolovich, JS Ginsberg, JD Douketis, AM Holbrook, G Cheah Archives of Internal Medicine 160 (2), 181-188, 2000 | 706 | 2000 |
| Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients F Dentali, JD Douketis, M Gianni, W Lim, MA Crowther Annals of internal medicine 146 (4), 278-288, 2007 | 703 | 2007 |
| Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials JW Eikelboom, DJ Quinlan, JD Douketis The Lancet 358 (9275), 9-15, 2001 | 684 | 2001 |
| Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates D Siegal, J Yudin, S Kaatz, JD Douketis, W Lim, AC Spyropoulos Circulation 126 (13), 1630-1639, 2012 | 569 | 2012 |
